Little T: "There seems to be a major disconnect in the Australian market with value and share price."
Little T/others: This is most CERTAINLY the case, i.e. that disconnect. But that is the case for ALL the biotech stocks listed in Australia - just a case of 'more or less' undervalued versus what the valuations would be in the USA. JIMHO, of course.
All the best to all NEU holders.
wasa
Ann: FDA reaffirms positive benefit-risk of ACADIA's NUPLAZID, page-14
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.10 |
Change
-0.800(5.76%) |
Mkt cap ! $1.629B | |||
| Open | High | Low | Value | Volume |
| $13.95 | $13.96 | $12.88 | $9.534M | 725.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 266 | $13.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.15 | 1619 | 2 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |